Get the latest news on Fidelity Disruptive Medicine ETF stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on FMED performance

Latest Fidelity Disruptive Medicine ETF  News | NASDAQ:FMED | Benzinga

Healthcare

Other

The fund investing at least 80 percent of assets in securities of disruptive medicine companies. Fidelity's disruptive strategies seek to identify innovative developments that could signal new directions for delivering products and services to customers. Generally, these companies have or are developing new or unconventional ways of doing business that could disrupt and displace incumbents over time. This may include creating, providing, or contributing to new or expanded business models, value networks, pricing, and delivery of products and services.

Boston Scientific Corp

Alnylam Pharmaceuticals

Unitedhealth Group Inc

Intuitive Surgical Inc

Danaher Corp

Insulet Corp

Centene Corp

Regeneron Pharmaceuticals Inc Common Stock Usd

Eli Lilly And Co

Stryker Corp

Fidelity Disruptive Medicine ETF

Comments

Fidelity Disruptive Medicine ETF Stock News

News

Latest Fidelity Disruptive Medicine ETF News | NASDAQ:FMED | Benzinga

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga